Navigation Links
Nobel Award in Medicine Holds Strong Messsage for Animal Activists
Date:10/9/2007

ALEXANDRIA, Va., Oct. 9 /PRNewswire-USNewswire/ -- The announcement of the 2007 Nobel Prize in Physiology or Medicine underscores the importance of laboratory animals in biomedical research. Americans for Medical Progress congratulates Mario R. Capecchi, Martin J. Evans and Oliver Smithies as they are honored by the Karolinska Institute for their animal-based research that pioneered gene targeting, technology now being used to develop treatments and cures for countless serious ailments.

"The Nobel Assembly's citation is a bold counterpoint to the dangerous agenda of animal rights leaders who are actively lobbying to stop scientists from conducting animal studies in disease research," said Jacquie Calnan, president of Americans for Medical Progress, a nonprofit organization that stands in support of biomedical research. "An end to animal-based research would be a critical blow to the health and well-being of people, pets, livestock and wildlife."

Ms. Calnan noted that the three scientists who share this year's Nobel Prize created the toolkit by which scientists are able to use mice to study heart disease, cancer, cystic fibrosis, hypertension and many other diseases. Already, several treatments have been developed and many more medicines are in the pipeline.

The citation by the Nobel Assembly stated: "Gene targeting has pervaded all fields of biomedicine. Its impact on the understanding of gene function and its benefits to mankind will continue to increase over many years to come."

Well over two-thirds of the Nobel Prizes in Physiology or Medicine have been awarded for research that has relied, at least in part, on animal studies. A survey of living Nobel laureates conducted to commemorate the centenary of Alfred Nobel's death found virtually unanimous agreement that animal research remains necessary if new treatments and cures are to be developed.

"Now would be a good time for animal rights leaders to step away from their opposition to animal studies and demonstrate support for humane and responsible research that benefits both people and animals," AMP's Calnan stated.

She added, "Scientists are steadfast in their dedication to extend and improve lives through biomedical research. They will not be deterred from their mission. The humane and judicious use of laboratory animals remains a vital component of their work."

Americans for Medical Progress is dedicated to informing the public about the humane, responsible and beneficial nature of animal-based biomedical research. AMP is supported by research stakeholders including universities, medical schools, life science research centers, professional societies, and, most importantly, patients who await treatments and cures. The website for Americans for Medical Progress details the importance of animal research, and the threat of animal rights extremism to advances in biomedical research. See http://www.amprogress.org.


'/>"/>
SOURCE Americans for Medical Progress
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Software exec Jan Eddy to receive "Seize the Day" award
2. Small Tree Communications awarded $2.85M defense contract
3. Alfalight awarded $1.7M from Army Research Lab
4. WMEP wins top economic development award
5. UW-Madisons Beebe wins scientific award
6. Mirus Bio awarded patent on RNA delivery
7. Green Bays ENCAP wins tech transfer award
8. TeachingBooks corrals AEP achievement award
9. Berbee wins two Microsoft awards
10. UWM announces winners of RGI awards
11. Madison company cosponsors young entrepreneur awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
Breaking Biology Technology:
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
Breaking Biology News(10 mins):